324 related articles for article (PubMed ID: 29219049)
1. Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy.
Waseem M; Kaushik P; Tabassum H; Parvez S
Curr Drug Metab; 2018; 19(1):47-54. PubMed ID: 29219049
[TBL] [Abstract][Full Text] [Related]
2. Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase.
Janes K; Doyle T; Bryant L; Esposito E; Cuzzocrea S; Ryerse J; Bennett GJ; Salvemini D
Pain; 2013 Nov; 154(11):2432-2440. PubMed ID: 23891899
[TBL] [Abstract][Full Text] [Related]
3. Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.
Ma J; Kavelaars A; Dougherty PM; Heijnen CJ
Cancer; 2018 Jun; 124(11):2289-2298. PubMed ID: 29461625
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy.
Trecarichi A; Flatters SJL
Int Rev Neurobiol; 2019; 145():83-126. PubMed ID: 31208528
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.
Sałat K
Pharmacol Rep; 2020 Jun; 72(3):486-507. PubMed ID: 32394362
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.
Sałat K
Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537
[TBL] [Abstract][Full Text] [Related]
7. Mini-Review: Mitochondrial dysfunction and chemotherapy-induced neuropathic pain.
Doyle TM; Salvemini D
Neurosci Lett; 2021 Aug; 760():136087. PubMed ID: 34182057
[TBL] [Abstract][Full Text] [Related]
8. Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain.
Brandolini L; d'Angelo M; Antonosante A; Allegretti M; Cimini A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197114
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.
Fumagalli G; Monza L; Cavaletti G; Rigolio R; Meregalli C
Front Immunol; 2020; 11():626687. PubMed ID: 33613570
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based Pharmacological Management of Chemotherapy-induced Neuropathic Pain from Preclinical Studies to Clinical Prospective: Platinum-based Drugs, Taxanes, and Vinca Alkaloids.
Zafari N; Velayati M; Maftooh M; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
Curr Pharm Des; 2023; 29(16):1245-1265. PubMed ID: 37190803
[TBL] [Abstract][Full Text] [Related]
11. An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models.
Bouchenaki H; Danigo A; Sturtz F; Hajj R; Magy L; Demiot C
Fundam Clin Pharmacol; 2021 Jun; 35(3):506-523. PubMed ID: 33107619
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
[TBL] [Abstract][Full Text] [Related]
13. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN).
Canta A; Pozzi E; Carozzi VA
Toxics; 2015 Jun; 3(2):198-223. PubMed ID: 29056658
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
16. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
[TBL] [Abstract][Full Text] [Related]
17. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.
Poupon L; Kerckhove N; Vein J; Lamoine S; Authier N; Busserolles J; Balayssac D
Expert Opin Drug Saf; 2015 Aug; 14(8):1269-82. PubMed ID: 26058312
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy.
Zajączkowska R; Kocot-Kępska M; Leppert W; Wrzosek A; Mika J; Wordliczek J
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909387
[TBL] [Abstract][Full Text] [Related]
19. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review.
Flatters SJL; Dougherty PM; Colvin LA
Br J Anaesth; 2017 Oct; 119(4):737-749. PubMed ID: 29121279
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.
Kerckhove N; Collin A; Condé S; Chaleteix C; Pezet D; Balayssac D
Front Pharmacol; 2017; 8():86. PubMed ID: 28286483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
